Craneware Plc(LSE) CRW

Craneware plc is a leading provider of software solutions tailored for the U.S. healthcare industry. The company specializes in creating applications that enhance operational efficiency and revenue management for healthcare organizations.

Products and Services

• Chargemaster Toolkit for automated charge master administration
• Trisus Supply for data consistency across systems
• Physician Revenue Toolkit for performance oversight and billing management

Growth Outlook

• Revenue increased to $106.2 million in Q2 2025, reflecting strong demand
• Net income reached $10.1 million in Q2 2025, showcasing profitability
• Annual revenue growth projected due to expanding healthcare software needs

Financial Highlights

• Trailing twelve months revenue of $406.5 million, indicating robust performance
• Net profit margin of 10.6% demonstrates effective cost management
• Dividend yield of 2.86% offers attractive returns to shareholders

Craneware plc has established itself as a vital player in the healthcare software sector, focusing on solutions that streamline operations and enhance revenue capture for healthcare providers. The company's flagship products, such as the Chargemaster Toolkit and Physician Revenue Toolkit, are designed to address critical needs in charge management and billing oversight. Recent financial performance highlights a significant increase in revenue and net income, reflecting the company's ability to capitalize on the growing demand for healthcare technology solutions. With a solid dividend yield and a strong profit margin, Craneware presents an appealing opportunity for investors interested in the healthcare information services industry. The ongoing expansion of healthcare software needs positions Craneware for continued growth in the coming years.